GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Debt-to-Revenue

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Pharbaco Central Pharmaceutical JSC No 1's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Pharbaco Central Pharmaceutical JSC No 1's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Pharbaco Central Pharmaceutical JSC No 1's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Pharbaco Central Pharmaceutical JSC No 1 Debt-to-Revenue Historical Data

The historical data trend for Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharbaco Central Pharmaceutical JSC No 1 Debt-to-Revenue Chart

Pharbaco Central Pharmaceutical JSC No 1 Annual Data
Trend
Debt-to-Revenue

Pharbaco Central Pharmaceutical JSC No 1 Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue falls into.



Pharbaco Central Pharmaceutical JSC No 1 Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Pharbaco Central Pharmaceutical JSC No 1's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Pharbaco Central Pharmaceutical JSC No 1 Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharbaco Central Pharmaceutical JSC No 1's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Headlines

No Headlines